17. Study characteristics
Cite each included study and present its characteristics.
Essential elements
- Cite each included study.
- Present the key characteristics of each study in a table or figure (considering a format that will facilitate comparison of characteristics across the studies).
Additional elements
- If the review examines the effects of interventions, consider presenting an additional table that summarises the intervention details for each study.
Explanation
Reporting the details of the included studies allows readers to understand the characteristics of studies that have addressed the review question(s) and is therefore important for understanding the applicability of the review. Characteristics of interest might include study design features, characteristics of participants, how outcomes were ascertained (such as smoking cessation self reported or biochemically validated, or specific harms systematically assessed or reported by participants as they emerged), funding source, and competing interests of study authors. Presenting the key characteristics of each study in a table or figure can facilitate comparison of characteristics across the studies.1 Citing each study enables retrieval of relevant reports if desired.
For systematic reviews of interventions, presenting an additional table that summarises the intervention details for each study (such as using the template based on the Template for Intervention Description and Replication (TIDieR)2) has several benefits. An intervention summary table helps readers compare the characteristics of the interventions and consider those that may be feasible for implementation in their setting; highlights missing or unavailable details; shows which studies did not specify certain characteristics as part of the intervention; and highlights characteristics that have not been investigated in existing studies.23
Example
In a review examining the association between aspirin use and fracture risk, the authors included a table presenting for each included study the citation, study design, country, sample size, setting, mean age, percentage of females, number of years follow-up, exposure details, and outcomes assessed (Table 1).4
Table 1: The table displays for each included study the citation, study design, country, sample size, setting, mean age, percentage of females, number of years follow-up, exposure details and outcomes assessed. Reproduced from Barker et al.4
Study ID Population Exposure to aspirin Outcomes Author (year) Study design Country Sample size Source of participants Age, mean Female, % Follow-up (years) Identification Dose Fracture Bone mineral density Bauer (1996) Cohort USA 7786 Community 73.1 100 1.6 Self-report 1–4 times/week ✓ ✓ 74.1 5–7 times/week Bleicher (2011) Cross-sectional Australia 1705 Community 77.0 0 – Medication verified in clinic NR – ✓ Bonten (2017) Cross-sectional Netherlands 854 Community 59.0 34 – Medication verified in clinic 30–125 mg/day ✓ ✓ Carbone (2003) Cross-sectional USA 2853 Community 73.6 50 – Medication verified in clinic 328 mg/day ✓ ✓ Chuang (2016) Case-control Taiwan 555 Community 74.0 61 5 Prescription history 106 mg ✓ – Dobnig (2007) Cohort Austria 1664 Nursing homes – 100 2 Not reported Not reported ✓ – Hill (2008) Cross-sectional Trinidad and Tobago 340 Community 63.9 100 – Medication verified in clinic ≥3 times/week – ✓ Hill (2008) Cross-sectional Trinidad and Tobago 2501 Community 56.3 0 – Self-report NR – ✓ Lane (1997) Cross-sectional USA 499 Community 73.6 100 – Self-report 5–7 days/week – ✓ Vestergaard (2006, 2012) Case-control Denmark 498 617 Community 43.4 52 1 Prescription history ≤150 mg/day ✓ – Vestergaard (2012) Cohort Denmark 2016 Community 50.8 100 10 Self-report 325 mg/day ✓ ✓
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.
Discuss this item
Visit this items’ discussion page to ask questions and give feedback.